NY-ESO-1


Protocolnummer:

Ziekenhuizen:
VU Medisch Centrum Amsterdam
Maastricht UMC+

Titel:
An open phase 1 study of immunization with recNY-ESO-1 +AS15 antigen-Specific Cancer Immunotherapeutic in patients with NY-ESO-1-positive unresectable and progressive metastatic cutanous melanoma.

Behandeling:
NY-ESO vaccine

Stadium:
Stadium irresectable IIIc/IV

Belangrijkste in/exclusiecriteria:
In: tumor shows expression of NY-ESO-1, >18yr, inoperable stage lll and stage lV a , LDH <1 UNL, ASAT / ALAT . Ex: any pretreatment

Contactpersoon:
Dr. F. van den Eertwegh ( VUMC)

Alle trials